Abstract: This research work introduces a clustering-based in-place sorting algorithm, cluster sort. It is designed in such a way that it improves sorting efficiency by using data locality. It works ...

RiSE coordinates Microsoft’s Research in Software Engineering in Redmond, USA. Our mission is to advance the state of the art in Software Engineering and to bring those advances to Microsoft’s ...

Brigham and Women’s Hospital nurses are speaking out in opposition to plans to merge the hospital’s burn unit with Mass General’s in 2026, which they argue damages generations of institutional ...

COLUMBUS, Ohio -- Ohio may start paying its small towns and villages to merge. A new bill at the statehouse would create a $25 million grant program to reward local governments that combine into one ...

Recursion Pharmaceuticals, Inc. leverages AI to accelerate drug discovery, offering both a licensing platform and an internal drug development pipeline. RXRX faces heavy competition, ongoing operating ...

Recursion Pharmaceuticals has designated its top research executive, Najat Khan, to succeed co-founder Chris Gibson as president and chief executive of the clinical-stage biotechnology company, ...

Mayor Brandon Johnson announced the program for migrants and homeless citizens will be downsizing in the new year. "So, we are now able to shift from a large-scale crisis response to a more cost ...

Basketball & STEM merge in new youth program A partnership is inspiring Valley children to get involved in STEM education by incorporating basketball. The Phoenix Mercury, Phoenix Suns & Honeywell ...

Recursion, a clinical-stage TechBio company, has successfully acquired Rallybio’s entire interest in their joint ENPP1 inhibitor program (REV102) aimed at treating hypophosphatasia (HPP), a rare ...

– Company Eligible to Receive Up to $25 Million, Including an Upfront Equity Payment of $7.5 Million – – Extends Rallybio Cash Runway to Mid-2027 – The REV102 program originated from a joint venture ...

– Company Eligible to Receive Up to $25 Million, Including an Upfront Equity Payment of $7.5 Million – – Extends Rallybio Cash Runway to Mid-2027 – Rallybio Corporation (Nasdaq: RLYB), a ...